NCT06907680View on ClinicalTrials.gov

M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Allergic Rhinitis Due to Grass Pollens
Interventions
DIETARY_SUPPLEMENT

M-Gard

One capsule containing 250mg of M-Gard Particulate EW is taken twice daily for 14 days.

OTHER

Placebo

One capsule containing 250mg of MCC (Microcrystalline Cellulose) is taken twice daily for 14 days.

Trial Locations (1)

4006

RECRUITING

RDC Clinical, Brisbane

All Listed Sponsors
collaborator

Lallemand Bio-Ingredients

OTHER

lead

RDC Clinical Pty Ltd

INDUSTRY